DMG-PEG2000
DMG-PEG2000 性质
| 储存条件 | -20°C, sealed storage, away from moisture and light |
|---|---|
| 溶解度 | 二甲基亚砜：100 mg/ml |
| 形态 | 结晶固体 |
| 颜色 | 白色至浅黄色 |
| 主要应用 | 先进药物递送 |
| InChIKey | NLDCRRFPGOSAHV-UHFFFAOYSA-N |
DMG-PEG2000 用途与合成方法
NP-3 (0.05-1.6 mg/mL; 24 hours) does not decrease the cytotoxicity of cells in 293T, HepG2, A549, and HeLa cell lines, but the DPPC and DMG-PEG coated nanoparticles reduce cell cytotoxicity. In addition, the transfection efficiency of DPPC/DMG-PEG/(lPEI/DNA) nanoparticles (NP-3) in 293 cells is improved, and the maximum transfection efficiency (∼76% eGFP positive cells) is observed.
NP-3 (oral administration; 150 μg DNA per mouse; single dose) at 12, 24, and 36 h postadministration, luciferin substrate is intraperitoneally injected to verify its permeability. NP-3 group maintains high luciferase expression in the liver, lung, and intestine areas 12-24 h post-treatment.Additionally, NP-3 exhibits 1.5 times higher signal intensity than that of NP-1 or NP-2 group from 12 to 24 h postoral administration.
DMG-PEG2000 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-06-05 | HY-112764GL | DMG-PEG2000 | 160743-62-4 | 10 mg | 750 |
| 2026-06-05 | HY-112764GL | DMG-PEG2000 | 160743-62-4 | 25 mg | 1500 |
